Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Feb
10
2016
FDA Unveils Action Plan to Combat Opioid Abuse
Jul
2
2018
Health Care Policy Newsletter: June 25-29, 2018
Jul
23
2018
Health Care Policy Newsletter July 16, 2018
May
25
2022
Medicare Advantage: OIG Report Finds Improper Denials
Jul
16
2018
Health Care Policy Newsletter: Week of July 9, 2018
Aug
23
2022
Proposed Revisions to Medicare Shared Savings Program: CMS Encourages Participation
Feb
23
2023
THC-Oh No! The DEA Classifies Delta-8 and Delta-9 THCO as Controlled Substances
Jul
30
2018
Health Care Policy Newsletter - Week of July 23-27, 2018
Mar
11
2022
FDA Publishes Proposed Rule on National Standards for The Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers as Required by The Drug Supply Chain Security Act
Mar
20
2019
An Artful Deal? Critics Question Administration’s Prescription Drug Negotiation Tools for Medicare Advantage
May
21
2018
Health Care Policy Newsletter
May
29
2018
Health Care Policy Newsletter - Week of May 28, 2019
Jul
31
2018
The Battle Over Drug Pricing: First Shot Targets Pharmacy Benefit Managers
Aug
28
2018
Public Policy August Recess Health Care Newsletter
Feb
14
2022
Top Trends in Tech-Enabled Home Care
May
2
2018
Direct Provider Contract Alternative Payment Model - CMS/CMMI Issues Request for Information
Mar
1
2023
North Carolina Senate Passes Compassionate Care Act – at Exactly 4:20 p.m.
Jul
9
2013
Public Water System Manager Found Guilty of Tampering with Drinking Water Samples After Trial
Jun
25
2018
Health Care Policy Newsletter - June 25, 2018
Mar
28
2019
Pharmacies: DOJ Wins TRO to Immediately Suspend Registration for Controlled Substances
Jul
25
2022
The French Decree on the Prohibition of Meat Designations for Plant-based Products
Jul
23
2019
Drug Pricing: White House Announces Withdrawal of Proposed Changes to Anti-Kickback Safe Harbors
May
30
2017
New FDA Commissioner Hits the Ground Running
Jun
6
2022
One Step Closer: N.C. Senate Passes Medical Cannabis Legislation
Jul
25
2022
EU Court of Justice on GMO Crop Ban
Aug
3
2020
FDA Issues Long-Awaited Draft Guidance on Cannabis Research
May
9
2022
South Carolina’s Medical Marijuana Bill Ruled Unconstitutional, but Sponsor Vows to Keep Fighting
Dec
29
2015
Don't Blame Patents For High Drug Prices
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins